Purpose. A3 adenosine receptor (A3AR) activation was shown to inhibit the growth of various tumor cells via the down-regulation of nuclear factor κB and cyclin D1. To additionally elucidate whether A 3AR is a specific target, a survey of its expression in tumor versus adjacent normal cells was conducted. Experimental Design: A3AR mRNA expression in various tumor tissues was tested in paraffin-embedded slides using reverse transcription-PCR analysis. A comparison with A3AR expression in the relevant adjacent normal tissue or regional lymph node metastasis was performed. In addition, A3AR protein expression was studied in fresh tumors and was correlated with that of the adjacent normal tissue. Results: Reverse transcription-PCR analysis of colon and breast carcinoma tissues showed higher A3AR expression in the tumor versus adjacent non-neoplastic tissue or normal tissue. Additional analysis revealed that the lymph node metastasis expressed even more A3AR mRNA than the primary tumor tissue. Protein analysis of A3AR expression in fresh tumors derived from colon (n = 40) or breast (n = 17) revealed that 61% and 78% had higher A3AR expression in the tumor versus normal adjacent tissue, respectively. The high A3AR expression level in the tumor tissues was associated with elevated nuclear factor κB and cyclin D1 levels. High A3AR mRNA expression was also demonstrated in other solid tumor types. Conclusions: Primary and metastatic tumor tissues highly express A3AR indicating that high receptor expression is a characteristic of solid tumors. These findings and our previous data suggest A3AR as a potential target for tumor growth inhibition.